ANTIBIOTICE IASI
78 articole · RSS
SIF Oltenia Reaches 23% Ownership In Antibiotice Iasi
Romanian state-owned Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, said in a stock market report on Wednesday that regional investment fund SIF Oltenia (SIF5.RO)...
Antibiotice Iasi Investments Double YoY To RON14M In 2020
Romanian state-owned Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, has invested RON14 million in new product research and equipment in 2020, double compared with...
Antibiotice Iasi Seeks to Distribute RON2.2M as Dividends
Romanian state-owned Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, plans to distribute RON2.2 million as dividends from its 2020 profit of RON26 million profit.
Antibiotice Iasi Net Profit Drops 16% in 2002, to RON25M
Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, on Thursday reported a 16% drop in net profit in 2002, to RON25 million.
Antibiotice Iasi Enters US and UK Markets with Covid-19 Medication
Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, has entered the US and UK markets with new medicines for Covid-19 by attending and winning tenders in the US and UK...
Antibiotice Iasi Extends CEO's Mandate For Four Years
Shareholders of state-owned Antibiotice Iasi (ATB.RO), one of the leading pharmaceutical manufacturers in Romania, on Wednesday approved the extension of the mandate of the company's executi...
Antibiotice Iasi Approves RON20M Dividends: 5.6% Yield
Shareholders of state-owned Antibiotice Iasi (ATB.RO), one of the leading pharmaceutical manufacturers in Romania, on Thursday approved the distribution of a gross dividend of RON0.029879738...
Antibiotice Iasi Net Profit Declines 10% in 2019, to RON30.8M
State-owned Antibiotice Iasi (ATB.RO), one of the leading local pharmaceutical manufacturers, said Thursday its net profit declined 10% in 2019, to RON30.8 million, while sales revenue grew...
Antibiotice Iasi Posts RON242M Sales, RON21.5M Net Profit In Jan-Sept 2019
Romanian state-owned pharmaceutical producer Antibiotice Iasi (ATB.RO) on Friday said it ended the first nine months of 2019 with sales revenue of RON242 million, comparable with the result...